Review
BibTex RIS Cite
Year 2018, Volume: 8 Issue: 4, 308 - 313, 28.12.2018

Abstract

References

  • 1] Levey AI, Kitt CA, Simonds WF, Price DL, Brann MR. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J Neurosci 1991; 11: 3218-26.

Muscarinic M1 and M2 receptors, fasting and seizure development in animals

Year 2018, Volume: 8 Issue: 4, 308 - 313, 28.12.2018

Abstract

Muscarinic M1 and M2 receptors are widely distributed in the brain and contribute to

various physiological and pathological functions. It is well known that enhancement of

cholinergic activity produces convulsions in animals. Pilocarpine, the M1 muscarinic

receptor agonist, is commonly used to induce seizures in rodents. On the other hand

it has been reported that fasted rats and mice pretreated with the M1 and M2 receptor

antagonist atropine, scopolamine or biperiden develop convulsions after food intake

indicating cholinergic hypoactivity as the underlying mechanism. This review will

present pharmacological data for the M1 and M2 receptors in the brain and focus on

the contrasting findings related to their contribution to convulsions.

References

  • 1] Levey AI, Kitt CA, Simonds WF, Price DL, Brann MR. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J Neurosci 1991; 11: 3218-26.
There are 1 citations in total.

Details

Primary Language English
Journal Section Articles
Authors

Merve Saygı Bacanak

Publication Date December 28, 2018
Submission Date April 7, 2017
Published in Issue Year 2018 Volume: 8 Issue: 4

Cite

APA Saygı Bacanak, M. (2018). Muscarinic M1 and M2 receptors, fasting and seizure development in animals. Clinical and Experimental Health Sciences, 8(4), 308-313.
AMA Saygı Bacanak M. Muscarinic M1 and M2 receptors, fasting and seizure development in animals. Clinical and Experimental Health Sciences. December 2018;8(4):308-313.
Chicago Saygı Bacanak, Merve. “Muscarinic M1 and M2 Receptors, Fasting and Seizure Development in Animals”. Clinical and Experimental Health Sciences 8, no. 4 (December 2018): 308-13.
EndNote Saygı Bacanak M (December 1, 2018) Muscarinic M1 and M2 receptors, fasting and seizure development in animals. Clinical and Experimental Health Sciences 8 4 308–313.
IEEE M. Saygı Bacanak, “Muscarinic M1 and M2 receptors, fasting and seizure development in animals”, Clinical and Experimental Health Sciences, vol. 8, no. 4, pp. 308–313, 2018.
ISNAD Saygı Bacanak, Merve. “Muscarinic M1 and M2 Receptors, Fasting and Seizure Development in Animals”. Clinical and Experimental Health Sciences 8/4 (December 2018), 308-313.
JAMA Saygı Bacanak M. Muscarinic M1 and M2 receptors, fasting and seizure development in animals. Clinical and Experimental Health Sciences. 2018;8:308–313.
MLA Saygı Bacanak, Merve. “Muscarinic M1 and M2 Receptors, Fasting and Seizure Development in Animals”. Clinical and Experimental Health Sciences, vol. 8, no. 4, 2018, pp. 308-13.
Vancouver Saygı Bacanak M. Muscarinic M1 and M2 receptors, fasting and seizure development in animals. Clinical and Experimental Health Sciences. 2018;8(4):308-13.

14639   14640